C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/37 (2006.01) A61K 49/00 (2006.01) C12Q 1/02 (2006.01) G01N 33/574 (2006.01)
Patent
CA 2714003
The invention describes methods that are useful for treating cancer by administering a Chk1 inhibitor which can induce apoptosis in p53-defective cells when combined with a chemotherapy and/or radiotherapy. Methods for screening candidates for a Chk1 inhibitor- based cancer treatment regimen are also described.
L'invention porte sur des procédés de traitement du cancer qui consistent à administrer un inhibiteur de Chk1 qui est capable d'induire l'apoptose dans des cellules déficientes en p53 lorsqu'il est combiné à une chimiothérapie et/ou une radiothérapie. L'invention concerne également des procédés qui permettent de cribler des candidats d'un régime thérapeutique anticancéreux à base d'inhibiteurs de Chk1.
Look A. Thomas
Sidi Samuel
Dana-Farber Cancer Institute Inc.
Smart & Biggar
LandOfFree
Chk1 suppresses a caspase-2 apoptotic response to dna damage... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chk1 suppresses a caspase-2 apoptotic response to dna damage..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chk1 suppresses a caspase-2 apoptotic response to dna damage... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1793807